Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 USD | -3.74% | -3.94% | +8.69% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 286M |
---|---|---|---|---|---|
Net income 2024 * | -101M | Net income 2025 * | -122M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.91
x | P/E ratio 2025 * |
-2.99
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.48% |
Latest transcript on Inozyme Pharma, Inc.
1 day | -3.74% | ||
1 week | -3.94% | ||
Current month | -3.94% | ||
1 month | -0.43% | ||
3 months | -27.09% | ||
6 months | +21.68% | ||
Current year | +8.69% |
Managers | Title | Age | Since |
---|---|---|---|
Axel Bolte
FOU | Founder | 52 | 15-08-31 |
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 20-04-30 |
Director of Finance/CFO | 48 | 22-03-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doug Treco Treco
CEO | Chief Executive Officer | 66 | 20-04-30 |
Reinaldo Diaz
BRD | Director/Board Member | 70 | 16-12-31 |
Axel Bolte
FOU | Founder | 52 | 15-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 32 M€ | +4.30% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 4.63 | -3.74% | 245,112 |
24-06-06 | 4.81 | -0.82% | 201,555 |
24-06-05 | 4.85 | +2.54% | 222,200 |
24-06-04 | 4.73 | -1.66% | 290,049 |
24-06-03 | 4.81 | -0.21% | 346,510 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.69% | 286M | |
+51.85% | 57.87B | |
+41.59% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- INZY Stock